SARAH A. L. MERRIAM, Magistrate Judge.
Pending before the Court is a motion by plaintiff Antonia Torcasio ("plaintiff") seeking reconsideration of the Court's Ruling on Motions to Compel [Doc. #76] with respect to plaintiff's interrogatory requests 19, 20, 21 and request for production 3. [Doc. #91]. Defendant Bruce Gluck ("Gluck") objects to plaintiff's motion. [Doc. #95]. For the reasons articulated below, the Court
The Court presumes familiarity with the factual background of this matter, which is recited in the Court's Ruling on Motions to Compel.
On December 2, 2015, plaintiff filed a motion seeking an order compelling Gluck to respond to numerous discovery requests. [Doc. #55]. As relevant here, plaintiff sought an order compelling Gluck to respond to three interrogatories (numbers 19, 20, 21) and one request for production (number 3), all regarding Gluck's prescribed medication and the names of the physicians with whom he was treating. [Doc. #55-2 at 3-4, 6].
The Court denied plaintiff's motion to compel with respect to these discovery requests for several reasons. First, the Court sustained Gluck's objections that these particular discovery requests were not reasonably calculated to lead to the discovery of admissible evidence. [Doc. #76 at 11]. The Court also rejected plaintiff's argument that the "medication issue" was "akin to a defense" because Gluck had not raised it as a defense, and it was unclear how Gluck's alleged medical condition could serve as a defense in light of the time frame of the alleged misconduct.
Plaintiff now seeks reconsideration of that portion of the Ruling on Motions to Compel pertaining to the medication issue on the grounds that new evidence, namely Gluck's December 17, 2015, deposition transcript, which was not available at the time of the filing of the motion to compel, undermines the Court's Ruling.
"The standard for granting [a motion for reconsideration] is strict, and reconsideration will generally be denied unless the moving party can point to controlling decisions or data that the court overlooked — matters, in other words, that might reasonably be expected to alter the conclusion reached by the court."
Plaintiff asserts two arguments in support of her motion for reconsideration, to which Gluck has objected. The Court will address each argument in turn.
Plaintiff first contends that Gluck's December 17, 2015, deposition testimony undermines the Court's observation, based on the evidence presented previously, that Gluck's medication issue apparently lasted for only one week's time. [Doc. #91-1 at 2-3]. Specifically, plaintiff points to various excerpts of Gluck's December 17, 2015, deposition for the proposition that his medication issue lasted from as early as 2009 to December 2010, meaning that contrary to the Court's observation that the evidence suggested this issue had a one-week impact, the medication issue in fact lasted up to two years. [Doc. #91-1 at 3]. Gluck's response is twofold. First, Gluck contends that plaintiff is merely trying to reargue that the information sought is relevant and reasonably calculated to lead to the discovery of admissible information. [Doc. #95 at 2]. Second, Gluck contends that the December 17, 2015, deposition transcript is not in fact "new evidence" in light of plaintiff's statement that Gluck testified similarly at his 2014 deposition.
The Court is hard-pressed to find that testimony offered at a December 17, 2015, deposition, at which plaintiff's counsel was in attendance, and which was (according to plaintiff) consistent with testimony offered in 2014, constitutes "new evidence" in regard to a ruling issued on January 25, 2016. If plaintiff's counsel felt that the December 17, 2015, deposition testimony was relevant to the arguments raised in the motion to compel, counsel should have alerted the Court to that fact while the motion was pending. Even assuming, however, that the December 17, 2015, deposition testimony is properly considered "newly discovered evidence," plaintiff's argument still misses the mark.
As set forth in the Ruling on Motions to Compel, the time frame at issue in plaintiff's Complaint ranges from, at a minimum, January 2010, through the date of the complaint, January 12, 2015.
Next, plaintiff speculatively argues that introduction of evidence at trial relating to Gluck's medication issue will "serve as a quasi-defense." [Doc. #91-1 at 4]. Plaintiff further elaborates that without the information requested in the discovery requests at issue, "Gluck could tell a jury as he wishes even though none of his assertions may be true, while the Plaintiff is simply left helpless to simply watch." [Doc. #91-1 at 4]. Gluck responds that plaintiff is "grasping at straws" and that at no point has he "relied on any aspect of his medical history to disavow responsibility for any of his conduct." [Doc. #95 at 3].
Plaintiff's argument simply reiterates the contentions in her original briefing. In her supplement to the motion to compel, plaintiff argued "Ostensibly, a jury could be persuaded that Gluck was a quasi-victim in all of this . . . The need to discover the accuracy of the `medication issue,' which is akin to a defense, is obviously material to the Plaintiff's case. Without requiring the production of such information, the Plaintiff is straightjacketed; Mr. Gluck can argue anything." [Doc. #70 at 3-4]. The motion for reconsideration simply parrots this argument and does not proffer a sufficient basis upon which to grant reconsideration. "A motion for reconsideration is `not simply a second bite at the apple for a party dissatisfied with a court's ruling.'"
Further, to the extent plaintiff contends that Gluck may try to use his medication issue as a form of a "quasi-defense" at trial, such concerns or potential for prejudice can be cured through a motion
For the reasons set forth herein, the Court
SO ORDERED.